Organization
Amarin Corporation Plc
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Amarin Corporation Plc
... BEDMINSTER - Amarin Corporation plc (NASDAQ: AMRN), a biopharmaceutical company focused on the commercialization and development ...
... 2018 BEDMINSTER, N.J. and DUBLIN, Ireland, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), today provided a business update, including an update on ...
... tohttp://www.wallstequities.com/registration. Featured this morning on WallStEquities.com are the following Drug Manufacturers stocks: Amarin Corp. PLC (NASDAQ: AMRN), Ionis Pharmaceuticals Inc. (NASDAQ: IONS), Endo International PLC ...
... BEDMINSTER, N.J., and DUBLIN, Ireland, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development ...
... BEDMINSTER, N.J., and DUBLIN, Ireland, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of ...
... million in the first six months of 2017. But when Salyer became Amarin's first chief commercial officer, his remit narrowed considerably. His primary responsibility will ...
... website:https://www.visiongain.com/Report/2071/Nonalcoholic-Steatohepatitis-(NASH)-Market-Report-to-2027 Companies Mentioned in the Report Abbott Laboratories AbbVie, Inc. Alkermes Plc Amarin Corp. Plc Amgen, Inc. Amnis Corporation Array BioPharma, Inc. Associates Of Cape ...
... BEDMINSTER, N.J. and DUBLIN, Ireland - Amarin Corporation plc (NASDAQ: AMRN), a biopharmaceutical company focused on the commercialization and development of ...
... BEDMINSTER, N.J. and DUBLIN - Amarin Corporation plc (NASDAQ: AMRN), a biopharmaceutical company focused on the commercialization and development of ...
... BEDMINSTER, N.J. and DUBLIN, Ireland, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development ...
... equities to see how they have fared over the previous trading sessions: Amarin Corp. PLC (NASDAQ: AMRN), Endo International PLC (NASDAQ: ENDP), Ionis Pharmaceuticals Inc. ...
... BEDMINSTER, N.J., and DUBLIN, Ireland, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of ...
... BEDMINSTER, N.J., and DUBLIN, Ireland - Amarin Corporation plc (NASDAQ: AMRN), a biopharmaceutical company focused on the commercialization and development of ...
... BEDMINSTER, N.J., and DUBLIN, Ireland - Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of ...
... DUBLIN (AP) _ Amarin Corp. PLC (AMRN) on Wednesday reported a loss of $10.8 million in ...
... ET BEDMINSTER, N.J., and DUBLIN, Ireland, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development ...
... BEDMINSTER, N.J., and DUBLIN - Amarin Corporation plc (NASDAQ: AMRN), a biopharmaceutical company focused on the commercialization and development of ...
... BEDMINSTER, N.J., and DUBLIN, Ireland, Oct. 25, 2017 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of ...
... companies that manufacture and process pharmaceutical products. Equities under assessment today are: Amarin Corp. PLC (NASDAQ: AMRN), Endo International PLC (NASDAQ: ENDP), Ionis Pharmaceuticals Inc. ...
... N.J., DUBLIN, Ireland, and TORONTO, Sept. 25, 2017 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) and HLS Therapeutics Inc. ("HLS"), announced today an exclusive agreement ...
... BEDMINSTER, N.J., and DUBLIN, Ireland, Sept. 20, 2017 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of ...
... Amarin announced Wednesday that it has named its first chief commercial officer, Mark ...
... BEDMINSTER, N.J. and DUBLIN, Ireland, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that Mark W. Salyer has joined Amarin as ...
... BEDMINSTER, N.J., and DUBLIN, Ireland, Sept. 06, 2017 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of ...
Want to see the full history on Amarin Corporation Plc? Upgrade to RelSci Pro now!
Start My Free Trial